EOM Pharmaceuticals Holdings, Inc.
IMUC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1 | $1 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $1 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2 | $2 | $3 | $3 |
| Operating Income | -$2 | -$2 | -$3 | -$3 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$0 | $0 | -$0 |
| Pre-Tax Income | -$2 | -$2 | -$3 | -$3 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$2 | -$2 | -$3 | -$3 |
| % Margin | – | – | – | – |
| EPS | -0.016 | -0.014 | -0.023 | -0.059 |
| % Growth | -15.5% | 39.3% | 60.3% | – |
| EPS Diluted | -0.016 | -0.014 | -0.023 | -0.059 |
| Weighted Avg Shares Out | 115 | 113 | 113 | 45 |
| Weighted Avg Shares Out Dil | 115 | 113 | 113 | 45 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $3 |
| EBITDA | -$1 | -$1 | -$2 | -$0 |
| % Margin | – | – | – | – |